Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

"Can't seem to keep my mind to it": did Arthur Miller's Salesman have dementia with Lewy bodies?

Fearon C, Taylor JP, O'Dowd S.

J Neurol. 2019 Jul;266(7):1806-1808. doi: 10.1007/s00415-019-09343-8. Epub 2019 Apr 30.

PMID:
31041580
2.

Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis.

Schumacher J, Cromarty R, Gallagher P, Firbank MJ, Thomas AJ, Kaiser M, Blamire AM, O'Brien JT, Peraza LR, Taylor JP.

J Neurol. 2019 Jul;266(7):1716-1726. doi: 10.1007/s00415-019-09323-y. Epub 2019 Apr 21.

PMID:
31006825
3.

Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.

King E, O'Brien J, Donaghy P, Williams-Gray CH, Lawson RA, Morris CM, Barnett N, Olsen K, Martin-Ruiz C, Burn D, Yarnall AJ, Taylor JP, Duncan G, Khoo TK, Thomas A.

Int J Geriatr Psychiatry. 2019 Apr 16. doi: 10.1002/gps.5124. [Epub ahead of print]

PMID:
30993722
4.

Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease.

Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O'Brien JT, Blamire AM, Taylor JP.

Neuroimage Clin. 2019;22:101812. doi: 10.1016/j.nicl.2019.101812. Epub 2019 Apr 3.

5.

C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function.

White MR, Mitrea DM, Zhang P, Stanley CB, Cassidy DE, Nourse A, Phillips AH, Tolbert M, Taylor JP, Kriwacki RW.

Mol Cell. 2019 May 16;74(4):713-728.e6. doi: 10.1016/j.molcel.2019.03.019. Epub 2019 Apr 10.

PMID:
30981631
6.

Corrigendum to "Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases" [Clin. Neurophysiol. 129 (2018) 766-782].

Babiloni C, Percio CD, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Garn H, Fraioli L, Pievani M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, De Pandis MF, Vacca L, Frisoni GB, Stocchi F.

Clin Neurophysiol. 2019 Jun;130(6):1078. doi: 10.1016/j.clinph.2019.02.006. Epub 2019 Apr 9. No abstract available.

PMID:
30979693
7.

ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97.

Wang B, Maxwell BA, Joo JH, Gwon Y, Messing J, Mishra A, Shaw TI, Ward AL, Quan H, Sakurada SM, Pruett-Miller SM, Bertorini T, Vogel P, Kim HJ, Peng J, Taylor JP, Kundu M.

Mol Cell. 2019 May 16;74(4):742-757.e8. doi: 10.1016/j.molcel.2019.03.027. Epub 2019 Apr 9.

PMID:
30979586
8.

Dysfunctional brain dynamics and their origin in Lewy body dementia.

Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O'Brien JT, Blamire AM, Taylor JP.

Brain. 2019 Jun 1;142(6):1767-1782. doi: 10.1093/brain/awz069.

9.

Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies.

Durcan R, Donaghy PC, Barnett NA, Olsen K, Yarnall AJ, Taylor JP, McKeith I, O'Brien JT, Thomas AJ.

Int J Geriatr Psychiatry. 2019 Jul;34(7):990-998. doi: 10.1002/gps.5100. Epub 2019 Apr 24.

PMID:
30901488
10.

123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults.

Roberts G, Lloyd JJ, Petrides GS, Donaghy PC, Kane JPM, Durcan R, Lawley S, Howe K, Sims AJ, Taylor JP, O'Brien JT, Thomas AJ.

Ann Nucl Med. 2019 Jun;33(6):434-443. doi: 10.1007/s12149-019-01352-x. Epub 2019 Mar 21.

PMID:
30900103
11.

Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology.

Zhang P, Fan B, Yang P, Temirov J, Messing J, Kim HJ, Taylor JP.

Elife. 2019 Mar 20;8. pii: e39578. doi: 10.7554/eLife.39578.

12.

Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease.

Nedelsky NB, Taylor JP.

Nat Rev Neurol. 2019 May;15(5):272-286. doi: 10.1038/s41582-019-0157-5. Review.

PMID:
30890779
13.

Noninvasive vagus nerve stimulation to target gait impairment in Parkinson's disease.

Morris R, Yarnall AJ, Hunter H, Taylor JP, Baker MR, Rochester L.

Mov Disord. 2019 Jun;34(6):918-919. doi: 10.1002/mds.27664. Epub 2019 Mar 19. No abstract available.

PMID:
30889295
14.

Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease.

King E, O'Brien JT, Donaghy P, Morris C, Barnett N, Olsen K, Martin-Ruiz C, Taylor JP, Thomas AJ.

Int Psychogeriatr. 2019 Apr;31(4):551-560. doi: 10.1017/S1041610218001126. Epub 2019 Mar 11.

PMID:
30854988
15.

Treatment Strategies and Survival Trends for Anorectal Melanoma: Is it Time for a Change?

Taylor JP, Stem M, Yu D, Chen SY, Fang SH, Gearhart SL, Safar B, Efron JE.

World J Surg. 2019 Jul;43(7):1809-1819. doi: 10.1007/s00268-019-04960-w.

PMID:
30830243
16.

Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases.

Babiloni C, Del Percio C, Pascarelli MT, Lizio R, Noce G, Lopez S, Rizzo M, Ferri R, Soricelli A, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Salvetti M, Cipollini V, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Aarsland D, Parnetti L, Farotti L, Marizzoni M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Hampel H, Frisoni GB, De Pandis MF, Bonanni L.

Neurobiol Aging. 2019 May;77:112-127. doi: 10.1016/j.neurobiolaging.2019.01.013. Epub 2019 Jan 24.

PMID:
30797169
17.

Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.

Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V, Gao J, Pandey A, Taylor JP, Kraemer BC, Wu P, Boldogh I, Garruto RM, Mitra S, Rao KS, Hegde ML.

Proc Natl Acad Sci U S A. 2019 Feb 15. pii: 201818415. doi: 10.1073/pnas.1818415116. [Epub ahead of print]

PMID:
30770445
18.

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.

McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Feb 13. pii: jnnp-2018-319581. doi: 10.1136/jnnp-2018-319581. [Epub ahead of print]

19.

Rare Inherited forms of Paget's Disease and Related Syndromes.

Ralston SH, Taylor JP.

Calcif Tissue Int. 2019 May;104(5):501-516. doi: 10.1007/s00223-019-00520-5. Epub 2019 Feb 13. Review.

PMID:
30756140
20.

Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C.

Neurosci Bull. 2019 Apr;35(2):295-300. doi: 10.1007/s12264-019-00341-4. Epub 2019 Feb 6. No abstract available.

PMID:
30729454
21.

Structural connectivity centrality changes mark the path toward Alzheimer's disease.

Peraza LR, Díaz-Parra A, Kennion O, Moratal D, Taylor JP, Kaiser M, Bauer R.

Alzheimers Dement (Amst). 2019 Jan 18;11:98-107. doi: 10.1016/j.dadm.2018.12.004. eCollection 2019 Dec.

22.

Imaging in prodromal dementia with Lewy bodies: Where do we stand?

Durcan R, Donaghy P, Osborne C, Taylor JP, Thomas AJ.

Int J Geriatr Psychiatry. 2019 May;34(5):635-646. doi: 10.1002/gps.5071. Epub 2019 Mar 15. Review.

PMID:
30714199
23.

Dementia with Lewy bodies: an update and outlook.

Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I.

Mol Neurodegener. 2019 Jan 21;14(1):5. doi: 10.1186/s13024-019-0306-8. Review.

24.

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial.

Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.

Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.

25.

A comparison of visual hallucinations across disorders.

Dudley R, Aynsworth C, Mosimann U, Taylor JP, Smailes D, Collerton D, McCarthy-Jones S, Urwyler P.

Psychiatry Res. 2019 Feb;272:86-92. doi: 10.1016/j.psychres.2018.12.052. Epub 2018 Dec 8.

PMID:
30579187
26.

The neural correlates of discrete gait characteristics in ageing: A structured review.

Wilson J, Allcock L, Mc Ardle R, Taylor JP, Rochester L.

Neurosci Biobehav Rev. 2019 May;100:344-369. doi: 10.1016/j.neubiorev.2018.12.017. Epub 2018 Dec 13. Review.

27.

Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer's Disease.

Cromarty RA, Schumacher J, Graziadio S, Gallagher P, Killen A, Firbank MJ, Blamire A, Kaiser M, Thomas AJ, O'Brien JT, Peraza LR, Taylor JP.

Front Aging Neurosci. 2018 Oct 30;10:347. doi: 10.3389/fnagi.2018.00347. eCollection 2018.

28.

TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle.

Vogler TO, Wheeler JR, Nguyen ED, Hughes MP, Britson KA, Lester E, Rao B, Betta ND, Whitney ON, Ewachiw TE, Gomes E, Shorter J, Lloyd TE, Eisenberg DS, Taylor JP, Johnson AM, Olwin BB, Parker R.

Nature. 2018 Nov;563(7732):508-513. doi: 10.1038/s41586-018-0665-2. Epub 2018 Oct 31.

29.

A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.

Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snædal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Mar;15(3):400-409. doi: 10.1016/j.jalz.2018.09.011. Epub 2018 Nov 12.

PMID:
30439333
30.

The Safety of Outpatient Stoma Closure: on the Verge of a Paradigm Shift?

Taylor JP, Stem M, Chen SY, Yu D, Fang SH, Gearhart SL, Safar B, Efron JE.

J Gastrointest Surg. 2018 Oct 22. doi: 10.1007/s11605-018-4001-9. [Epub ahead of print]

PMID:
30350192
31.

Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms.

Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Fraioli L, Parnetti L, Farotti L, Pievani M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Frisoni GB, De Pandis MF.

Neurobiol Aging. 2019 Jan;73:9-20. doi: 10.1016/j.neurobiolaging.2018.08.010. Epub 2018 Aug 30.

PMID:
30312790
32.

The utility and application of electrophysiological methods in the study of visual hallucinations.

daSilva Morgan K, Elder GJ, Ffytche DH, Collerton D, Taylor JP.

Clin Neurophysiol. 2018 Nov;129(11):2361-2371. doi: 10.1016/j.clinph.2018.08.019. Epub 2018 Sep 6. Review.

PMID:
30253375
33.

Altered Nucleus Basalis Connectivity Predicts Treatment Response in Mild Cognitive Impairment.

Meng D, Li X, Bauer M, Taylor JP, Auer DP; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2018 Dec;289(3):775-785. doi: 10.1148/radiol.2018180092. Epub 2018 Sep 11.

PMID:
30204076
34.

Meet your surgical team: The impact of a resident-led quality improvement project on patient satisfaction.

Craig-Schapiro R, DiBrito SR, Overton HN, Taylor JP, Fransman RB, Haut ER, Sacks BC.

Am J Surg. 2018 Oct;216(4):793-799. doi: 10.1016/j.amjsurg.2018.07.056. Epub 2018 Aug 27.

35.

Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study.

Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J.

Int J Geriatr Psychiatry. 2018 Oct;33(10):1293-1304. doi: 10.1002/gps.4948. Epub 2018 Aug 9. No abstract available.

36.

Reduced occipital GABA in Parkinson disease with visual hallucinations.

Firbank MJ, Parikh J, Murphy N, Killen A, Allan CL, Collerton D, Blamire AM, Taylor JP.

Neurology. 2018 Aug 14;91(7):e675-e685. doi: 10.1212/WNL.0000000000006007. Epub 2018 Jul 18.

37.

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Pajtler KW, Wen J, Sill M, Lin T, Orisme W, Tang B, Hübner JM, Ramaswamy V, Jia S, Dalton JD, Haupfear K, Rogers HA, Punchihewa C, Lee R, Easton J, Wu G, Ritzmann TA, Chapman R, Chavez L, Boop FA, Klimo P, Sabin ND, Ogg R, Mack SC, Freibaum BD, Kim HJ, Witt H, Jones DTW, Vo B, Gajjar A, Pounds S, Onar-Thomas A, Roussel MF, Zhang J, Taylor JP, Merchant TE, Grundy R, Tatevossian RG, Taylor MD, Pfister SM, Korshunov A, Kool M, Ellison DW.

Acta Neuropathol. 2018 Aug;136(2):211-226. doi: 10.1007/s00401-018-1877-0. Epub 2018 Jun 16.

PMID:
29909548
38.

Linking hnRNP Function to ALS and FTD Pathology.

Purice MD, Taylor JP.

Front Neurosci. 2018 May 15;12:326. doi: 10.3389/fnins.2018.00326. eCollection 2018. Review.

39.

Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study.

Lawson RA, Collerton D, Taylor JP, Burn DJ, Brittain KR.

Parkinsons Dis. 2018 Apr 8;2018:1362053. doi: 10.1155/2018/1362053. eCollection 2018.

40.

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.

Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O'Brien JT.

Psychol Med. 2019 Feb;49(3):396-402. doi: 10.1017/S0033291718000995. Epub 2018 Apr 25.

41.

Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

Guo L, Kim HJ, Wang H, Monaghan J, Freyermuth F, Sung JC, O'Donovan K, Fare CM, Diaz Z, Singh N, Zhang ZC, Coughlin M, Sweeny EA, DeSantis ME, Jackrel ME, Rodell CB, Burdick JA, King OD, Gitler AD, Lagier-Tourenne C, Pandey UB, Chook YM, Taylor JP, Shorter J.

Cell. 2018 Apr 19;173(3):677-692.e20. doi: 10.1016/j.cell.2018.03.002.

42.

Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?

McAleese KE, Walker L, Colloby SJ, Taylor JP, Thomas AJ, DeCarli C, Attems J.

Brain. 2018 Jun 1;141(6):e44. doi: 10.1093/brain/awy084. No abstract available.

PMID:
29668888
43.

Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis.

Stylianou M, Murphy N, Peraza LR, Graziadio S, Cromarty R, Killen A, O' Brien JT, Thomas AJ, LeBeau FEN, Taylor JP.

Clin Neurophysiol. 2018 Jun;129(6):1209-1220. doi: 10.1016/j.clinph.2018.03.013. Epub 2018 Apr 3.

44.

Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.

Zhang K, Daigle JG, Cunningham KM, Coyne AN, Ruan K, Grima JC, Bowen KE, Wadhwa H, Yang P, Rigo F, Taylor JP, Gitler AD, Rothstein JD, Lloyd TE.

Cell. 2018 May 3;173(4):958-971.e17. doi: 10.1016/j.cell.2018.03.025. Epub 2018 Apr 5.

45.

Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM.

Mov Disord. 2018 Jul;33(6):982-991. doi: 10.1002/mds.27333. Epub 2018 Mar 23.

PMID:
29570843
46.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

47.

Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report.

Pottier C, Rampersaud E, Baker M, Wu G, Wuu J, McCauley JL, Zuchner S, Schule R, Bermudez C, Hussain S, Cooley A, Wallace M, Zhang J, Taylor JP, Benatar M, Rademakers R.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):469-471. doi: 10.1080/21678421.2018.1452947. Epub 2018 Mar 20.

PMID:
29558868
48.

Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer's disease patients.

Peraza LR, Cromarty R, Kobeleva X, Firbank MJ, Killen A, Graziadio S, Thomas AJ, O'Brien JT, Taylor JP.

Sci Rep. 2018 Mar 15;8(1):4637. doi: 10.1038/s41598-018-22984-5.

49.

An International Approach to Enhancing a National Guideline on Driving and Dementia.

Rapoport MJ, Chee JN, Carr DB, Molnar F, Naglie G, Dow J, Marottoli R, Mitchell S, Tant M, Herrmann N, Lanctôt KL, Taylor JP, Donaghy PC, Classen S, O'Neill D.

Curr Psychiatry Rep. 2018 Mar 12;20(3):16. doi: 10.1007/s11920-018-0879-x. Review.

PMID:
29527643
50.

Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions.

Dao TP, Kolaitis RM, Kim HJ, O'Donovan K, Martyniak B, Colicino E, Hehnly H, Taylor JP, Castañeda CA.

Mol Cell. 2018 Mar 15;69(6):965-978.e6. doi: 10.1016/j.molcel.2018.02.004. Epub 2018 Mar 8.

Supplemental Content

Loading ...
Support Center